companydata.dkcompanydata.dk

Merck Life Science A/S: Financial statements 2023

CVR: 20830131

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 1,398,642,419 and a net result of DKK 73,609,980 compared with DKK 46,001,362 the year before. That is an increase of 11.3% compared with the year before. The profit margin was 5.3%. Equity in the 2023 report amounted to DKK 239,855,470. The solvency ratio was 74.3%. The company had 24 employees in the financial year.

Revenue
DKK 1,398,642,419
Gross Profit
DKK 119,753,156
Profit/Loss
DKK 73,609,980
Equity
DKK 239,855,470
Total Assets
DKK 322,676,626
Employees
24

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20231.4B119.8M73.6M239.9M24
20221.3B80.1M46M166.2M20
20211B69.8M37.7M214.7M16
2020768.2M72.1M41.3M177M16
2019-53.4M27.4M135.7M9

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Merck Life Science A/S wins public contractNov 10, 2023

Merck Life Science A/S has won the tender "Udbud af rammeaftale vedr. avancerede kemikalier" issued by Aalborg Universitet.

Merck Life Science A/S: The 2022 annual report is outMay 15, 2023

Merck Life Science A/S has published its annual report for 2022. Revenue came to DKK 1,256,087,140, and the net result was DKK 46,001,362.

Merck Life Science A/S appoints new auditorMay 11, 2023

As of May 11, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Merck Life Science A/S.

Auditor steps down at Merck Life Science A/SMay 11, 2023

As of May 11, 2023, KPMG P/S has stepped down as auditor of Merck Life Science A/S.

Anders Gerner Petersen joins the board of Merck Life Science A/SMar 1, 2023

As of March 1, 2023, Anders Gerner Petersen has joined the board of directors of Merck Life Science A/S.

David Mouyal leaves the board of Merck Life Science A/SMar 1, 2023

As of March 1, 2023, David Mouyal has left the board of directors of Merck Life Science A/S.

About Merck Life Science A/S

Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.

Source: annual report 2025, Danish Business Authority